APO Research
Talk to an analyst

APO RESEARCH · REPORT

Paclitaxel and Docetaxel

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Paclitaxel and Docetaxel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025192 pages

Choose your research edition.

Industry ResearchPaclitaxel and Docetaxel Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Paclitaxel and Docetaxel Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Paclitaxel and Docetaxel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Paclitaxel and Docetaxel Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Paclitaxel and Docetaxel Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Paclitaxel and Docetaxel market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Paclitaxel and Docetaxel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Paclitaxel and Docetaxel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Paclitaxel and Docetaxel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Paclitaxel and Docetaxel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Paclitaxel and Docetaxel include Yunnan Hande, Southpharma, Hainan Yew Pharm, TAPI (Teva), ScinoPharm, Samyang, Polymed, Phyton and Novasep, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Paclitaxel and Docetaxel market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Paclitaxel and Docetaxel and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Paclitaxel and Docetaxel sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Paclitaxel and Docetaxel market size, projected growth trends, production technologies, key applications, and end-use industries.

Paclitaxel and Docetaxel Segment by Company

Yunnan Hande

Southpharma

Hainan Yew Pharm

TAPI (Teva)

ScinoPharm

Samyang

Polymed

Phyton

Novasep

Jiangsu Yew Biotechnology

Huiang biopharma

Fresenius-kabi

Paclitaxel and Docetaxel Segment by Type

Paclitaxel

Docetaxel

Paclitaxel and Docetaxel Segment by Application

Cervical Cancer

Ovarian Cancer

Breast Cancer

Others

Paclitaxel and Docetaxel Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paclitaxel and Docetaxel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Paclitaxel and Docetaxel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paclitaxel and Docetaxel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Paclitaxel and Docetaxel market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Paclitaxel and Docetaxel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Paclitaxel and Docetaxel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Paclitaxel and Docetaxel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Paclitaxel and Docetaxel Industry Trends Table 2. Paclitaxel and Docetaxel Industry Drivers Table 3. Paclitaxel and Docetaxel Industry Opportunities and Challenges Table 4. Paclitaxel and Docetaxel Industry Restraints Table 5. Global Paclitaxel and Docetaxel Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Paclitaxel and Docetaxel Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Paclitaxel and Docetaxel Sales by Manufacturers (K Tons) & (2021-2026) Table 8. Global Paclitaxel and Docetaxel Sales Market Share by Manufacturers Table 9. Global Paclitaxel and Docetaxel Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Paclitaxel and Docetaxel Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Paclitaxel and Docetaxel Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Paclitaxel and Docetaxel Manufacturers, Product Type & Application Table 13. Global Paclitaxel and Docetaxel Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Paclitaxel and Docetaxel by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Paclitaxel Table 17. Major Manufacturers of Docetaxel Table 18. Global Paclitaxel and Docetaxel Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 19. Global Paclitaxel and Docetaxel Sales by Type (2021-2026) & (K Tons) Table 20. Global Paclitaxel and Docetaxel Sales by Type (2027-2032) & (K Tons) Table 21. Global Paclitaxel and Docetaxel Sales Market Share by Type (2021-2026) Table 22. Global Paclitaxel and Docetaxel Sales Market Share by Type (2027-2032) Table 23. Global Paclitaxel and Docetaxel Revenue by Type 2021 VS 2025 VS 2032 (K Tons) Table 24. Global Paclitaxel and Docetaxel Revenue by Type (2021-2026) & (K Tons) Table 25. Global Paclitaxel and Docetaxel Revenue by Type (2027-2032) & (K Tons) Table 26. Global Paclitaxel and Docetaxel Revenue Market Share by Type (2021-2026) Table 27. Global Paclitaxel and Docetaxel Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cervical Cancer Table 29. Major Manufacturers of Ovarian Cancer Table 30. Major Manufacturers of Breast Cancer Table 31. Major Manufacturers of Others Table 32. Global Paclitaxel and Docetaxel Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 33. Global Paclitaxel and Docetaxel Sales by Application (2021-2026) & (K Tons) Table 34. Global Paclitaxel and Docetaxel Sales by Application (2027-2032) & (K Tons) Table 35. Global Paclitaxel and Docetaxel Sales Market Share by Application (2021-2026) Table 36. Global Paclitaxel and Docetaxel Sales Market Share by Application (2027-2032) Table 37. Global Paclitaxel and Docetaxel Revenue by Application 2021 VS 2025 VS 2032 (K Tons) Table 38. Global Paclitaxel and Docetaxel Revenue by Application (2021-2026) & (K Tons) Table 39. Global Paclitaxel and Docetaxel Revenue by Application (2027-2032) & (K Tons) Table 40. Global Paclitaxel and Docetaxel Revenue Market Share by Application (2021-2026) Table 41. Global Paclitaxel and Docetaxel Revenue Market Share by Application (2027-2032) Table 42. Global Paclitaxel and Docetaxel Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 43. Global Paclitaxel and Docetaxel Sales by Region (2021-2026) & (K Tons) Table 44. Global Paclitaxel and Docetaxel Sales Market Share by Region (2021-2026) Table 45. Global Paclitaxel and Docetaxel Sales Forecasted by Region (2027-2032) & (K Tons) Table 46. Global Paclitaxel and Docetaxel Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Paclitaxel and Docetaxel Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 48. North America Paclitaxel and Docetaxel Sales by Country (2021-2026) & (K Tons) Table 49. North America Paclitaxel and Docetaxel Sales by Country (2027-2032) & (K Tons) Table 50. Europe Paclitaxel and Docetaxel Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 51. Europe Paclitaxel and Docetaxel Sales by Country (2021-2026) & (K Tons) Table 52. Europe Paclitaxel and Docetaxel Sales by Country (2027-2032) & (K Tons) Table 53. Asia Pacific Paclitaxel and Docetaxel Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 54. Asia Pacific Paclitaxel and Docetaxel Sales by Country (2021-2026) & (K Tons) Table 55. Asia Pacific Paclitaxel and Docetaxel Sales by Country (2027-2032) & (K Tons) Table 56. South America, Middle East and Africa Paclitaxel and Docetaxel Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 57. South America, Middle East and Africa Paclitaxel and Docetaxel Sales by Country (2021-2026) & (K Tons) Table 58. South America, Middle East and Africa Paclitaxel and Docetaxel Sales by Country (2027-2032) & (K Tons) Table 59. Global Paclitaxel and Docetaxel Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Paclitaxel and Docetaxel Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Paclitaxel and Docetaxel Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Paclitaxel and Docetaxel Revenue Market Share by Region (2021-2026) Table 63. Global Paclitaxel and Docetaxel Revenue Market Share by Region (2027-2032) Table 64. Yunnan Hande Company Information Table 65. Yunnan Hande Business Overview Table 66. Yunnan Hande Paclitaxel and Docetaxel Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Yunnan Hande Paclitaxel and Docetaxel Product Portfolio Table 68. Yunnan Hande Recent Development Table 69. Southpharma Company Information Table 70. Southpharma Business Overview Table 71. Southpharma Paclitaxel and Docetaxel Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Southpharma Paclitaxel and Docetaxel Product Portfolio Table 73. Southpharma Recent Development Table 74. Hainan Yew Pharm Company Information Table 75. Hainan Yew Pharm Business Overview Table 76. Hainan Yew Pharm Paclitaxel and Docetaxel Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Hainan Yew Pharm Paclitaxel and Docetaxel Product Portfolio Table 78. Hainan Yew Pharm Recent Development Table 79. TAPI (Teva) Company Information Table 80. TAPI (Teva) Business Overview Table 81. TAPI (Teva) Paclitaxel and Docetaxel Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. TAPI (Teva) Paclitaxel and Docetaxel Product Portfolio Table 83. TAPI (Teva) Recent Development Table 84. ScinoPharm Company Information Table 85. ScinoPharm Business Overview Table 86. ScinoPharm Paclitaxel and Docetaxel Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. ScinoPharm Paclitaxel and Docetaxel Product Portfolio Table 88. ScinoPharm Recent Development Table 89. Samyang Company Information Table 90. Samyang Business Overview Table 91. Samyang Paclitaxel and Docetaxel Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Samyang Paclitaxel and Docetaxel Product Portfolio Table 93. Samyang Recent Development Table 94. Polymed Company Information Table 95. Polymed Business Overview Table 96. Polymed Paclitaxel and Docetaxel Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Polymed Paclitaxel and Docetaxel Product Portfolio Table 98. Polymed Recent Development Table 99. Phyton Company Information Table 100. Phyton Business Overview Table 101. Phyton Paclitaxel and Docetaxel Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Phyton Paclitaxel and Docetaxel Product Portfolio Table 103. Phyton Recent Development Table 104. Novasep Company Information Table 105. Novasep Business Overview Table 106. Novasep Paclitaxel and Docetaxel Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Novasep Paclitaxel and Docetaxel Product Portfolio Table 108. Novasep Recent Development Table 109. Jiangsu Yew Biotechnology Company Information Table 110. Jiangsu Yew Biotechnology Business Overview Table 111. Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Product Portfolio Table 113. Jiangsu Yew Biotechnology Recent Development Table 114. Huiang biopharma Company Information Table 115. Huiang biopharma Business Overview Table 116. Huiang biopharma Paclitaxel and Docetaxel Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Huiang biopharma Paclitaxel and Docetaxel Product Portfolio Table 118. Huiang biopharma Recent Development Table 119. Fresenius-kabi Company Information Table 120. Fresenius-kabi Business Overview Table 121. Fresenius-kabi Paclitaxel and Docetaxel Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Fresenius-kabi Paclitaxel and Docetaxel Product Portfolio Table 123. Fresenius-kabi Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Paclitaxel and Docetaxel Distributors List Table 127. Paclitaxel and Docetaxel Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Paclitaxel and Docetaxel Product Image Figure 2. Global Paclitaxel and Docetaxel Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Paclitaxel and Docetaxel Market Size (2021-2032) & (US$ Million) Figure 4. Global Paclitaxel and Docetaxel Sales (2021-2032) & (K Tons) Figure 5. Global Paclitaxel and Docetaxel Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Paclitaxel and Docetaxel Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Paclitaxel Image Figure 9. Docetaxel Image Figure 10. Global Paclitaxel and Docetaxel Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 11. Global Paclitaxel and Docetaxel Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Paclitaxel and Docetaxel Sales Market Share by Type (2021-2032) Figure 13. Global Paclitaxel and Docetaxel Revenue by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 14. Global Paclitaxel and Docetaxel Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Paclitaxel and Docetaxel Revenue Market Share by Type (2021-2032) Figure 16. Cervical Cancer Image Figure 17. Ovarian Cancer Image Figure 18. Breast Cancer Image Figure 19. Others Image Figure 20. Global Paclitaxel and Docetaxel Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 21. Global Paclitaxel and Docetaxel Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Paclitaxel and Docetaxel Sales Market Share by Application (2021-2032) Figure 23. Global Paclitaxel and Docetaxel Revenue by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 24. Global Paclitaxel and Docetaxel Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Paclitaxel and Docetaxel Revenue Market Share by Application (2021-2032) Figure 26. North America Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 27. North America Paclitaxel and Docetaxel Sales Market Share by Country (2021-2032) Figure 28. U.S. Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 29. Canada Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 30. Mexico Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 31. Europe Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 32. Europe Paclitaxel and Docetaxel Sales Market Share by Country (2021-2032) Figure 33. Germany Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 34. France Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 35. U.K. Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 36. Italy Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 37. Netherlands Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 38. Asia Pacific Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 39. Asia Pacific Paclitaxel and Docetaxel Sales Market Share by Country (2021-2032) Figure 40. China Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 41. Japan Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 42. South Korea Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 43. Southeast Asia Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 44. India Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 45. Australia Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 46. South America, Middle East and Africa Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 47. South America, Middle East and Africa Paclitaxel and Docetaxel Sales Market Share by Country (2021-2032) Figure 48. Brazil Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 49. South Africa Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 50. Saudi Arabia Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 51. Turkey Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 52. Argentina Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 53. UAE Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 54. Egypt Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 55. Chile Paclitaxel and Docetaxel Sales and Growth Rate (2021-2032) & (K Tons) Figure 56. Global Paclitaxel and Docetaxel Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Paclitaxel and Docetaxel Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Paclitaxel and Docetaxel Revenue (2021-2032) & (US$ Million) Figure 59. North America Paclitaxel and Docetaxel Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Paclitaxel and Docetaxel Revenue (2021-2032) & (US$ Million) Figure 61. Europe Paclitaxel and Docetaxel Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Paclitaxel and Docetaxel Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Paclitaxel and Docetaxel Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Paclitaxel and Docetaxel Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Paclitaxel and Docetaxel Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Paclitaxel and Docetaxel Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Paclitaxel and Docetaxel Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Paclitaxel
  • Docetaxel
Applications
  • Cervical Cancer
  • Ovarian Cancer
  • Breast Cancer
  • Others
Companies covered
  • Yunnan Hande
  • Southpharma
  • Hainan Yew Pharm
  • TAPI (Teva)
  • ScinoPharm
  • Samyang
  • Polymed
  • Phyton
  • Novasep
  • Jiangsu Yew Biotechnology
  • Huiang biopharma
  • Fresenius-kabi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Paclitaxel and Docetaxel Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Paclitaxel and Docetaxel Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Paclitaxel and Docetaxel Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Paclitaxel and Docetaxel Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Paclitaxel and Docetaxel Market Dynamics
  1. 2.1 Paclitaxel and Docetaxel Industry Trends
  2. 2.2 Paclitaxel and Docetaxel Industry Drivers
  3. 2.3 Paclitaxel and Docetaxel Industry Opportunities and Challenges
  4. 2.4 Paclitaxel and Docetaxel Industry Restraints
3 Paclitaxel and Docetaxel Market by Manufacturers
  1. 3.1 Global Paclitaxel and Docetaxel Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Paclitaxel and Docetaxel Sales by Manufacturers (2021-2026)
  3. 3.3 Global Paclitaxel and Docetaxel Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Paclitaxel and Docetaxel Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Paclitaxel and Docetaxel Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Paclitaxel and Docetaxel Manufacturers, Product Type & Application
  7. 3.7 Global Paclitaxel and Docetaxel Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Paclitaxel and Docetaxel Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Paclitaxel and Docetaxel Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Paclitaxel and Docetaxel Tier 1, Tier 2, and Tier 3
4 Paclitaxel and Docetaxel Market by Type
  1. 4.1 Paclitaxel and Docetaxel Type Introduction
  2. 4.1.1 Paclitaxel
  3. 4.1.2 Docetaxel
  4. 4.2 Global Paclitaxel and Docetaxel Sales by Type
  5. 4.2.1 Global Paclitaxel and Docetaxel Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Paclitaxel and Docetaxel Sales by Type (2021-2032)
  7. 4.2.3 Global Paclitaxel and Docetaxel Sales Market Share by Type (2021-2032)
  8. 4.3 Global Paclitaxel and Docetaxel Revenue by Type
  9. 4.3.1 Global Paclitaxel and Docetaxel Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Paclitaxel and Docetaxel Revenue by Type (2021-2032)
  11. 4.3.3 Global Paclitaxel and Docetaxel Revenue Market Share by Type (2021-2032)
5 Paclitaxel and Docetaxel Market by Application
  1. 5.1 Paclitaxel and Docetaxel Application Introduction
  2. 5.1.1 Cervical Cancer
  3. 5.1.2 Ovarian Cancer
  4. 5.1.3 Breast Cancer
  5. 5.1.4 Others
  6. 5.2 Global Paclitaxel and Docetaxel Sales by Application
  7. 5.2.1 Global Paclitaxel and Docetaxel Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Paclitaxel and Docetaxel Sales by Application (2021-2032)
  9. 5.2.3 Global Paclitaxel and Docetaxel Sales Market Share by Application (2021-2032)
  10. 5.3 Global Paclitaxel and Docetaxel Revenue by Application
  11. 5.3.1 Global Paclitaxel and Docetaxel Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Paclitaxel and Docetaxel Revenue by Application (2021-2032)
  13. 5.3.3 Global Paclitaxel and Docetaxel Revenue Market Share by Application (2021-2032)
6 Global Paclitaxel and Docetaxel Sales by Region
  1. 6.1 Global Paclitaxel and Docetaxel Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Paclitaxel and Docetaxel Sales by Region (2021-2032)
  3. 6.2.1 Global Paclitaxel and Docetaxel Sales by Region (2021-2026)
  4. 6.2.2 Global Paclitaxel and Docetaxel Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Paclitaxel and Docetaxel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Paclitaxel and Docetaxel Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Paclitaxel and Docetaxel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Paclitaxel and Docetaxel Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Paclitaxel and Docetaxel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Paclitaxel and Docetaxel Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Paclitaxel and Docetaxel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Paclitaxel and Docetaxel Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Paclitaxel and Docetaxel Revenue by Region
  1. 7.1 Global Paclitaxel and Docetaxel Revenue by Region
  2. 7.1.1 Global Paclitaxel and Docetaxel Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Paclitaxel and Docetaxel Revenue by Region (2021-2026)
  4. 7.1.3 Global Paclitaxel and Docetaxel Revenue by Region (2027-2032)
  5. 7.1.4 Global Paclitaxel and Docetaxel Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Paclitaxel and Docetaxel Revenue (2021-2032)
  8. 7.2.2 North America Paclitaxel and Docetaxel Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Paclitaxel and Docetaxel Revenue (2021-2032)
  11. 7.3.2 Europe Paclitaxel and Docetaxel Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Paclitaxel and Docetaxel Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Paclitaxel and Docetaxel Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Paclitaxel and Docetaxel Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Paclitaxel and Docetaxel Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yunnan Hande
  2. 8.1.1 Yunnan Hande Company Information
  3. 8.1.2 Yunnan Hande Business Overview
  4. 8.1.3 Yunnan Hande Paclitaxel and Docetaxel Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yunnan Hande Paclitaxel and Docetaxel Product Portfolio
  6. 8.1.5 Yunnan Hande Recent Developments
  7. 8.2 Southpharma
  8. 8.2.1 Southpharma Company Information
  9. 8.2.2 Southpharma Business Overview
  10. 8.2.3 Southpharma Paclitaxel and Docetaxel Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Southpharma Paclitaxel and Docetaxel Product Portfolio
  12. 8.2.5 Southpharma Recent Developments
  13. 8.3 Hainan Yew Pharm
  14. 8.3.1 Hainan Yew Pharm Company Information
  15. 8.3.2 Hainan Yew Pharm Business Overview
  16. 8.3.3 Hainan Yew Pharm Paclitaxel and Docetaxel Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hainan Yew Pharm Paclitaxel and Docetaxel Product Portfolio
  18. 8.3.5 Hainan Yew Pharm Recent Developments
  19. 8.4 TAPI (Teva)
  20. 8.4.1 TAPI (Teva) Company Information
  21. 8.4.2 TAPI (Teva) Business Overview
  22. 8.4.3 TAPI (Teva) Paclitaxel and Docetaxel Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 TAPI (Teva) Paclitaxel and Docetaxel Product Portfolio
  24. 8.4.5 TAPI (Teva) Recent Developments
  25. 8.5 ScinoPharm
  26. 8.5.1 ScinoPharm Company Information
  27. 8.5.2 ScinoPharm Business Overview
  28. 8.5.3 ScinoPharm Paclitaxel and Docetaxel Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ScinoPharm Paclitaxel and Docetaxel Product Portfolio
  30. 8.5.5 ScinoPharm Recent Developments
  31. 8.6 Samyang
  32. 8.6.1 Samyang Company Information
  33. 8.6.2 Samyang Business Overview
  34. 8.6.3 Samyang Paclitaxel and Docetaxel Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Samyang Paclitaxel and Docetaxel Product Portfolio
  36. 8.6.5 Samyang Recent Developments
  37. 8.7 Polymed
  38. 8.7.1 Polymed Company Information
  39. 8.7.2 Polymed Business Overview
  40. 8.7.3 Polymed Paclitaxel and Docetaxel Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Polymed Paclitaxel and Docetaxel Product Portfolio
  42. 8.7.5 Polymed Recent Developments
  43. 8.8 Phyton
  44. 8.8.1 Phyton Company Information
  45. 8.8.2 Phyton Business Overview
  46. 8.8.3 Phyton Paclitaxel and Docetaxel Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Phyton Paclitaxel and Docetaxel Product Portfolio
  48. 8.8.5 Phyton Recent Developments
  49. 8.9 Novasep
  50. 8.9.1 Novasep Company Information
  51. 8.9.2 Novasep Business Overview
  52. 8.9.3 Novasep Paclitaxel and Docetaxel Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Novasep Paclitaxel and Docetaxel Product Portfolio
  54. 8.9.5 Novasep Recent Developments
  55. 8.10 Jiangsu Yew Biotechnology
  56. 8.10.1 Jiangsu Yew Biotechnology Company Information
  57. 8.10.2 Jiangsu Yew Biotechnology Business Overview
  58. 8.10.3 Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jiangsu Yew Biotechnology Paclitaxel and Docetaxel Product Portfolio
  60. 8.10.5 Jiangsu Yew Biotechnology Recent Developments
  61. 8.11 Huiang biopharma
  62. 8.11.1 Huiang biopharma Company Information
  63. 8.11.2 Huiang biopharma Business Overview
  64. 8.11.3 Huiang biopharma Paclitaxel and Docetaxel Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Huiang biopharma Paclitaxel and Docetaxel Product Portfolio
  66. 8.11.5 Huiang biopharma Recent Developments
  67. 8.12 Fresenius-kabi
  68. 8.12.1 Fresenius-kabi Company Information
  69. 8.12.2 Fresenius-kabi Business Overview
  70. 8.12.3 Fresenius-kabi Paclitaxel and Docetaxel Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Fresenius-kabi Paclitaxel and Docetaxel Product Portfolio
  72. 8.12.5 Fresenius-kabi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Paclitaxel and Docetaxel Value Chain Analysis
  2. 9.1.1 Paclitaxel and Docetaxel Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Paclitaxel and Docetaxel Production Mode & Process
  6. 9.2 Paclitaxel and Docetaxel Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Paclitaxel and Docetaxel Distributors
  9. 9.2.3 Paclitaxel and Docetaxel Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst